Literature DB >> 12776009

Pathophysiology of congestive heart failure.

Gary S Francis1, W H Wilson Tang.   

Abstract

Heart failure is a clinical syndrome characterized by impaired structure and/or function of the heart, leading to dyspnea and fatigue at rest or with exertion. The pathophysiology of heart failure is complex, and there is no single lesion. Any form of heart disease can lead to heart failure. Most heart failure can be explained by well-recognized etiologic factors, though ostensibly healthy patients may harbor risk factors for the later development of heart failure. A fundamental response to myocardial injury or altered loading conditions includes "remodeling" of the heart, so that the size, shape, and function of the affected chamber is grossly distorted. This is accompanied by a constellation of biologic changes, best recognized in advanced cases of heart failure. These multiple alterations may be primary or secondary events but, nonetheless, add importantly to the morbidity and mortality of the patients. More emphasis should be placed on recognition and correction of risk factors related to the development of heart failure.

Entities:  

Mesh:

Year:  2003        PMID: 12776009

Source DB:  PubMed          Journal:  Rev Cardiovasc Med        ISSN: 1530-6550            Impact factor:   2.930


  19 in total

Review 1.  Evolving concepts in left ventricular systolic and diastolic remodeling: implications for therapy.

Authors:  W H Wilson Tang; Gary S Francis
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

Review 2.  Rodent models of heart failure: an updated review.

Authors:  A C Gomes; I Falcão-Pires; A L Pires; C Brás-Silva; A F Leite-Moreira
Journal:  Heart Fail Rev       Date:  2013-03       Impact factor: 4.214

Review 3.  Practical Pharmacogenomic Approaches to Heart Failure Therapeutics.

Authors:  Chayakrit Krittanawong; Amalia Namath; David E Lanfear; W H Wilson Tang
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-10

4.  Serum Level of Heart-Type Fatty Acid Binding Protein (H-FABP) Before and After Treatment of Congestive Heart Failure in Children.

Authors:  Amr Zoair; Wegdan Mawlana; Amany Abo-Elenin; Mostafa Korrat
Journal:  Pediatr Cardiol       Date:  2015-06-30       Impact factor: 1.655

Review 5.  Molecular changes occurring during reverse remodelling following left ventricular assist device support.

Authors:  Emma J Birks; Robert S George
Journal:  J Cardiovasc Transl Res       Date:  2010-09-04       Impact factor: 4.132

Review 6.  Is heart failure different on the two continents (North America and Europe)?

Authors:  Rachel Hughes-Doichev; Mark E Dunlap
Journal:  Curr Cardiol Rep       Date:  2004-05       Impact factor: 2.931

Review 7.  Pharmacogenomics in heart failure: where are we now and how can we reach clinical application?

Authors:  Akinyemi Oni-Orisan; David E Lanfear
Journal:  Cardiol Rev       Date:  2014 Sep-Oct       Impact factor: 2.644

8.  Key pathways associated with heart failure development revealed by gene networks correlated with cardiac remodeling.

Authors:  Zhong Gao; Andreas S Barth; Deborah DiSilvestre; Fadi G Akar; Yanli Tian; Antti Tanskanen; David A Kass; Raimond L Winslow; Gordon F Tomaselli
Journal:  Physiol Genomics       Date:  2008-09-09       Impact factor: 3.107

Review 9.  Tumor Necrosis Factor-α in Heart Failure: an Updated Review.

Authors:  Sarah M Schumacher; Sathyamangla V Naga Prasad
Journal:  Curr Cardiol Rep       Date:  2018-09-26       Impact factor: 2.931

10.  The role of exercise on L-arginine nitric oxide pathway in chronic heart failure.

Authors:  A C Mendes-Ribeiro; G E Mann; L R de Meirelles; M B Moss; C Matsuura; T M C Brunini
Journal:  Open Biochem J       Date:  2009-10-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.